[Use of disaggregants in treating diabetic retinopathy].
D001205:Ascorbic Acid / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002123:Calcium Dobesilate / Q000627:therapeutic use; D003925:Diabetic Angiopathies / Q000188:drug therapy / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D004176:Dipyridamole / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D010431:Pentoxifylline / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects*; D012431:Rutin / Q000627:therapeutic use; D013916:Thrombelastography; D014785:Vision, Ocular / Q000502:physiology
D004338:Drug Combinations; C044488:ascorbic acid, rutoside drug combination; D002123:Calcium Dobesilate; D012431:Rutin; D004176:Dipyridamole; D001205:Ascorbic Acid; D001241:Aspirin; D010431:Pentoxifylline
Primenenie dezagregantov v lechenii diabeticheskoĭ retinopatii.